• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Swinging for Christ









Now that's a hoot. After all, read what the founder said, “I don’t think God would be mad at what we are doing, At first I was conflicted, but the more we looked at it, the more it makes sense to us."

Hell yes!!! Use what you were given. Use it or lose it.

http://fitnessswingers.com/